JPMorgan Chase & Co. Has Lowered Expectations for Afya (NASDAQ:AFYA) Stock Price

Afya (NASDAQ:AFYA) had its price target dropped by stock analysts at JPMorgan Chase & Co. from $25.00 to $20.50 in a research note issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 30.24% from the stock’s current price.

Separately, The Goldman Sachs Group began coverage on Afya in a research report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $19.60.

Afya Stock Performance

NASDAQ AFYA opened at $15.74 on Friday. Afya has a 12 month low of $14.52 and a 12 month high of $22.48. The company’s 50 day moving average is $15.92 and its two-hundred day moving average is $16.74. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60.

Hedge Funds Weigh In On Afya

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio purchased a new position in Afya during the third quarter valued at approximately $34,000. Quarry LP bought a new position in shares of Afya in the 3rd quarter worth $75,000. Centiva Capital LP bought a new stake in Afya during the third quarter valued at about $213,000. Quantbot Technologies LP raised its holdings in Afya by 73.8% in the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after purchasing an additional 5,636 shares in the last quarter. Finally, Lifestyle Asset Management Inc. boosted its holdings in shares of Afya by 5.5% in the 4th quarter. Lifestyle Asset Management Inc. now owns 17,682 shares of the company’s stock valued at $281,000 after buying an additional 929 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.